December 08, 2014
Nordic Nanovector presented phase I study data reporting promising clinical activity in patients with relapsed non-Hodgkin lymphoma at ASH
Media
December 06, 2014
Nordic Nanovector intends to undertake private placement of NOK 150 million
December 06, 2014
Bayer completes voluntary takeover offer for Algeta
December 05, 2014
Oncopeptides Presents Encouraging Preliminary Phase I/ II Clinical Data with Melflufen and Dexamethasone for Patients with Relapsed and Relapsed-Refractory Multiple Myeloma at the 56th ASH Annual Meeting and Exposition.
December 04, 2014
Oncos Therapeutics recruits Dr Magnus Jaderberg as CMO
December 02, 2014
Nordic Nanovector To Present Clinical Data from Phase I/II Trial on Betalutin™ at Upcoming American Society of Hematology (ASH) Meeting
December 02, 2014
Cerenis Therapeutics reports two postivie phase II studies
December 02, 2014
Oncos Therapeutics granted US and EU Orphan Drug Designation
December 02, 2014
Aerocrine announce that NICE guidelines support the FeNO measurement in diagnosis and management of asthma
December 02, 2014
Cerenis Reports Top-Line Phase II Results for its HDL Mimetic CER-001
